Posted on June 25, 2008 by crimsoncanary
Axelar has initiated a Phase I/II clinical trial in cancer patients with its insulin-like growth factor-1 receptor inhibitor AXL1717
Filed under: Kinase receptor | Tagged: Axelar, AXL-1717, AXL1717, IGF-1R, IGF-R1, phase I, Phase II, phase iii | Comments Off
Posted on June 25, 2008 by crimsoncanary
ImClone have commenced a Phase 1 clinical trial of IGF-1R MAb in combination with mTOR inhibitor temsirolimus in patients with advanced solid malignancies and lymphoma.
Filed under: kinase | Tagged: IGF-1R, IGF-R1, IMC-A12, IMCA12, mTOR, temsirolimus | Comments Off
